Source link : https://www.newshealth.biz/health-news/colchicine-a-new-tool-for-stroke-cvd-event-recurrence/
BASEL, SWITZERLAND — The anti-inflammatory agent colchicine failed to show significant benefit in the treatment of patients with non-cardioembolic ischemic stroke in the primary analysis of the CONVINCE trial. However, the results did reveal a significant reduction in recurrent stroke and cardiovascular events in the per-protocol analysis and in the subgroup of patients with coronary […]
Author : News Health
Publish date : 2024-05-29 13:14:54
Copyright for syndicated content belongs to the linked Source.
in Health